Accelerated Approval: Mid-Review Decisions ‘Not The Norm’ But Will Continue, FDA’s Cavazzoni says

 
• By Sue Sutter
Exception to the rule
Mid-review decisions to use accelerated approval are the exception to the rule on early interactions regarding surrogates and confirmatory trial planning. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards